logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

Are the new ISA rules 'disproportionate to risk'?

11 December 2009

Seven main representative organisations for schools and college leaders have written to Ed Balls requesting changes to the vetting and barring scheme stating the new rules are 'bureaucratic and will not guarantee safety'. This is not the first time government has been criticised over the scheme, leading to it considering the complaints in a recent review.

The signatories claim that the requirement for volunteers to register with the ISA mean there will be a reduction in the support from parents and student helpers in schools, help that Head, Julie Robinson, vice-chairman of the Independent Association of Prep Schools, says is genuinely needed.

With the review out imminently it will be interesting to see how the DCSF and the ISA reacts having been on the receiving end of such broad and public criticism. There is no doubt the system needed an over-haul but has the pendulum swung too far and now risks deterring genuine volunteers?

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mark Blois

Mark Blois

Partner and Head of Education

View profile

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up